New metal-based drugs: spectral, electrochemical, DNA-binding and anticancer activity properties

Mustafa Çeşme*, Harun Muslu, Mehmet Tumer, Özge Güngör, Mine Altunbek, Mustafa Culha, Aysegul Golcu

*Bu çalışma için yazışmadan sorumlu yazar

Araştırma sonucu: Dergiye katkıMakalebilirkişi

Özet

The coordination compounds of antineoplastic chemotherapy drug of dacarbazine (DAC) with Zn(II) ([Zn(DAC)2] 3H2O; NGDCM1) and Cu(II) ([Cu(DAC)ClH2O]; NGDCM2) were synthesized and characterized using analytical and spectroscopic techniques. The electrochemical behaviors of the obtained new compounds and the starting active substance DAC were examined in detail. The interaction of all compounds with fish sperm double-stranded deoxyribonucleic acid (FSdsDNA) was investigated by measuring their binding constant (Kb) to FSdsDNA. Also, the competitive binding fluorescence spectroscopy studies with ethidium bromide (EtBr) were carried out. Furthermore, both compound’s anticancer activities were investigated on human lung cancer (A549) cells, and their effects were compared to other metals possessing antineoplastic drugs, including oxaliplatin and cisplatin.

Orijinal dilİngilizce
Sayfa (başlangıç-bitiş)165-176
Sayfa sayısı12
DergiInorganic and Nano-Metal Chemistry
Hacim54
Basın numarası2
DOI'lar
Yayın durumuYayınlandı - 2024

Bibliyografik not

Publisher Copyright:
© 2021 Taylor & Francis Group, LLC.

Finansman

The authors wish to thank TUBITAK (Project No: 112T721, COST/CM1105) for the financial supports.

FinansörlerFinansör numarası
TUBITAK112T721, COST/CM1105

    Parmak izi

    New metal-based drugs: spectral, electrochemical, DNA-binding and anticancer activity properties' araştırma başlıklarına git. Birlikte benzersiz bir parmak izi oluştururlar.

    Alıntı Yap